Ove Østergaard
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Parathyroid Disorders and Treatments
- Gastroenterology top 10%
Papers in
-
- Gastrointestinal Bleeding Diagnosis and Treatment 1
- Gastrointestinal motility and disorders 1
-
- Parathyroid Disorders and Treatments 1
- Co-authors
- Scott Chasan-Taber (1 shared paper)Ajay Duggal (1 shared paper)Stanley L. Fan (1 shared paper)Markus Ketteler (1 shared paper)Marianne Rix (1 shared paper)Jeremy P.W. Heaton (1 shared paper)Philip A. Kalra (1 shared paper)Knud Rasmussen (2 shared papers)
In The Last Decade
Ove Østergaard
9 papers receiving 698 citations
Ove Østergaard's Hit Papers
Peers
Comparison fields: 5 of 56
- Nephrology 453
- Gastroenterology 26
- Cardiology and Cardiovascular Medicine 74
- Hematology 37
- Endocrinology, Diabetes and Metabolism 44
Countries citing papers authored by Ove Østergaard
This map shows the geographic impact of Ove Østergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ove Østergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ove Østergaard more than expected).
Fields of papers citing papers by Ove Østergaard
This network shows the impact of papers produced by Ove Østergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ove Østergaard. The network helps show where Ove Østergaard may publish in the future.
Co-authors
The 21 scholars most cited alongside Ove Østergaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 527 |
| 2 | 2008 | 72 | |
| 3 | 2017 | 35 | |
| 4 | 2016 | 31 | |
| 5 | [Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo]. | 1988 | 27 |
| 6 | 2014 | 17 | |
| 7 | 1995 | 15 | |
| 8 | 1987 | 5 | |
| 9 | 2011 | 3 |
About Ove Østergaard
Ove Østergaard is a scholar working on Gastroenterology, Nephrology, Hematology, Cardiology and Cardiovascular Medicine and Pharmaceutical Science, having authored 9 papers that have together received 732 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (2 papers), Potassium and Related Disorders (1 paper), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), Drug Solubulity and Delivery Systems (1 paper), Vitamin D Research Studies (1 paper), Heart rate and cardiovascular health (1 paper), Parathyroid Disorders and Treatments (1 paper) and Gastrointestinal motility and disorders (1 paper). The work is most often cited by research in Nephrology (453 citations), Gastroenterology (26 citations), Cardiology and Cardiovascular Medicine (74 citations), Hematology (37 citations) and Endocrinology, Diabetes and Metabolism (44 citations). Ove Østergaard has collaborated with scholars based in Denmark, Germany and Norway. Frequent co-authors include Scott Chasan-Taber, Ajay Duggal, Stanley L. Fan, Markus Ketteler, Marianne Rix, Jeremy P.W. Heaton, Philip A. Kalra, Knud Rasmussen, Niels Erik Frandsen and Lars Ødum. Their work appears in journals such as PLoS ONE, Nephrology Dialysis Transplantation, European Heart Journal, The Lancet and Clinical Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.